Quality of life in patients with multiple myeloma: early rehabilitation is need of the hour
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20220102Keywords:
Assessment, Functioning, Multiple Myeloma, Quality of Life, RehabilitationAbstract
Background: Multiple myeloma (MM) is a debilitating disease leading to reduced functioning. Evaluation of rehabilitative needs is necessary to provide rehabilitative care which may improve the functional status and quality of life (QOL) of such patients. We aimed to assess the rehabilitative needs, as well as levels of QOL in patients diagnosed with MM.
Methods: Ninety consecutive patients were included in this cross-sectional survey. All patients (new and relapsed), irrespective of disease status and duration from diagnosis, underwent baseline evaluation following which they completed a scale exploring their functional status by Barthel mobility index scoring and QOL with the European organization of research and training in cancer QOL questionnaire with its MM module. Mean score and frequency (%) were calculated. Comparison of scores between different categories was analyzed.
Results: Mean age was 57 years±10.1 (32 to 85 years). The QOL was low (39±18.2), with key areas of impairment being physical (100%), emotional (95.5%), role (91%), social (87.7%) and cognitive (68.8%) functioning. Low mean QOL score was found in all patients irrespective of treatment, clinical response and duration from diagnosis. There was improvement in quality-of-life score with treatment, though it did not cross the minimal important difference range.
Conclusions: There was significant reduction in quality-of-life score and functioning. This study emphasizes the need to assess rehabilitation needs among patients of MM to optimize the management.
Metrics
References
Kyle RA, Rajkumar SV. Multiple Myeloma. Blood. 2008;111:2962-72.
Comert M, Guines AE, Satin F, Saydem G. Quality of life and supportive care in Multiple Myeloma. Turk J haematol. 2013;30(3):234-46.
Kumar L, Verma R, Radhakrishnan VR. Recent advances in management of multiple myeloma. Natl Med J India. 2010;23:210-8.
Rebecca S, Kimberley M, Ahmedin J. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30.
Charles A, Lloyd E. Blood Disorders. In: Stephen J, Maxine A, Michael W, (ed). Current Medical Diagnosis and Treatment. 56th ed. San Francisco (CA): McGraw-Hill; 2015:499-545.
Palumbo A, Rajkumar SV, San Miguel JF, Larocca A, Niesvizky R, Morgan G et al. International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol. 2014;32(6):587-600.
Bergsagel PL, Mateos MV, Gutierrez NC, Rajkumar SV, San Miguel JF. Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma. Blood. 2013;121(6):884-92.
Castelli R, Gualtierotti R, Orofino N, Losurdo A, Gandolfi S, Cugno M. Current and Emerging Treatment Options for Patients with Relapsed Myeloma. Clin Med Insights Oncol. 2013;7:209-19.
Ocio EM, Richardson PG, Rajkumar SV. New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG). Leukemia. 2014;28(3):525-42.
Kouroukis CT, Baldassarre FG, Haynes AE, Imrie K, Reece DE, Cheung MC. Bortezomib in multiple myeloma: a practice guideline. Clin Oncol (R Coll Radiol). 2014;26(2):110-19.
Scott LJ. Pomalidomide: a review of its use in patients with recurrent multiple myeloma. Drugs. 2014;74(5):549-62.
Fratino L, Rupolo M, Mazzuccato M, Berretta M, Lleshi A, Tirelli U et al. Autologus stem cell transplatation as a care option in elderly patients. Anticancer Agents Med Chem. 2013;13(9):1419-29.
Who.int. Geneva (CH): WHO. Rehabilitation. Available at: http://www.who.int/topics/rehabilitation/en/. Accessed on 18 Oct 2021.
Galvao DA, Newton RU. Review of exercise intervention studies in cancer. J Clin Oncol. 2005;23:900-909.
Mikkelsen TH, Sondergaard J, Jensen AB, Olesen F. Cancer rehabilitation: psychosocial rehabilitation needs after discharge from hospital. Scand J Prim Care. 2008;26(4):216-21.
Groeneveldt L, Mein G, Garrod R, Jewell AP, Van Soeren K, Stephens R et al. A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer. 2013;13:31.
Holm LV, Hansen DG, Johansen C, Vedsted P, Larsen PV, Kragstrup J et al. Participation in cancer rehabilitation and unmet needs: a population-based cohort study. Support Care Cancer. 2012;20(11):2913-24.
Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M. Health related quality of life in a nationally representative sample of hematological patients. Eur J Haematol. 2009;83(2):139-48.
Movsas SB, Chang VT, Tunkel RS, Shah VV, Ryan LS, Millis SR. Rehabilitation needs of an inpatient medical oncology unit. Arch Phys Med Rehabil. 2003;84(11):1642-6.
Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology. 2011;20(1):88-97.
Slovacek L, Slovackova B, Pavlik V, Hrstka Z, Maingova Z, Jebavy L et al. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis. Neoplasma. 2008;55(4):350-55.
Fayers P, Aaronson NK, Bjordal K, Groenvold M, Crran D, Bottomley A et al. The EORTC QLQ-C30 Scoring Manual. Brussels: European Organization for Research and Treatment of Cancer. 2001. Available at: https://www.eortc.be/qol/files/SCManualQLQ-C30.pdf. Accessed on 18 Oct 2021.
Cocks K, Cohen D, Wisloff F, Sezer O, Lee S, Hippe G et al. An international field study of the reliability and validity of a diseases specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007;43:1670-8.
Scott NW, Fayers PM, Aoronson NK, Bottomley A, Graeff A, Groenvold et al. EORTC QLQ-C30 Reference Values. Brussels: 2008. Available at: https://www.eortc.org/app/uploads/sites/2/2018/02/reference_values_manual2008.pdf. Accessed on 18 Oct 2021.
Mahoney F, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J. 1965;14:56-61.
Stroke center.org. Dallas (TX): The Internet Stroke Center. Available at: www.strokecenter.org/professionals/stroke-diagnosis/stroke-assessment-scales/barthel/. Accessed on 19 Oct 2021.
Young J. Rehabilitation: General principles. In: Fillit HM, Rockwood K, Woodhouse K, (ed). Brocklehurst’s Textbook of Geriatric medicine and Gerontology. 7th ed. Philadelphia (PA): Elsevier. 2010:1-21.
Lewis C, Shaw K. The (Original) Barthel Index of ADLs. Physical therapy Rehab Med. 2006;17(21):8.
Sonneveld P, Verelst SG, Lewis P, Grey-Schopfer V, Hutchings A, Nixon V et al. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia. 2013;27:1959-69.
Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud. 1988;10(2):61-3.
Bairwa M, Rajput M, Sachdeva S. Modified Kuppuswamy’s Socioeconomic Scale: Social researcher should include updated income criteria, 2012. Indian J Community Med. 2013;38(3):185-6.
Gan JH, Cim CYL, Santorelli LA. The effectiveness of exercise programmes in patients with multiple myeloma: A literature review. Critical Reviews in Oncology/Hematology. 2016;98:275-89.
Stucki G, Daltry L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of parts. J Clin Epidemiol. 1996;49(7):711-7.
Parker PA, Baile WF, De Moor C, Cohen L. Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology. 2003;12:183-93.
Kim YM, Kim DY. Cancer Rehabilitation: Experience, Symptoms, and Needs. J Korean Med Sci 2011;26(5):619-24.
Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11):2577-92.
